Jun Shen

Jun Shen

Auto-generated profile, based on publicly available information

Jun Shen

Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA O2115, USA.

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2015 in Genetics in Medicine
Verified
Journal Article
Closed access
AAAhmed A. Alfares
Ahmed A. Alfares
MKMelissa A. Kelly
Melissa A. Kelly
GMGregory McDermott
Gregory McDermott
BFBirgit H. Funke
Birgit H. Funke
MLMatthew Lebo
Matthew Lebo
HHeidi Rehm
Heidi Rehm

22 April 2015 in The Journal of Neuroscience
Verified
Journal Article
Open access
PDF file
DSDéborah I. Scheffer
Déborah I. Scheffer
JSJun Shen
Jun Shen
DCDavid P. Corey
David P. Corey
ZCZheng-Yi Chen
Zheng-Yi Chen
Hair cells of the inner ear are essential for hearing and balance. As a consequence, pathogenic variants in genes specifically expressed in hair cells often cause hereditary deafness. Hair cells are few in number and not easily isolated from the adjacent supporting cells, so the biochemistry and molecular biology of hair cells can be difficult to study. To study gene expression in hair cells, we developed a protocol for hair cell isolation by FACS. With nearly pure hair cells and surrounding cells, from cochlea and utricle and from E16 to P7, we performed a comprehensive cell type-specific RNA-Seq study of gene expression during mouse inner ear development. Expression profiling revealed new hair cell genes with distinct expression patterns: some are specific for vestibular hair cells, others for cochlear hair cells, and some are expressed just before or after maturation of mechanosensitivity. We found that many of the known hereditary deafness genes are much more highly expressed in hair cells than surrounding cells, suggesting that genes preferentially expressed in hair cells are good candidates for unknown deafness genes.

1 November 2019 in Genetics in Medicine
Verified
Journal Article
Closed access
PDF file
JSJun Shen
Jun Shen
AOAndrea M. Oza
Andrea M. Oza
Ignacio del CastilloIgnacio del Castillo
Ignacio del Castillo
HDHatice Duzkale
Hatice Duzkale
TMTatsuo Matsunaga
Tatsuo Matsunaga
LSLisa Schimmenti
Lisa Schimmenti

1 November 2019 in Genetics in Medicine
Verified
Journal Article
Open access
PDF file
ASA. Eliot Shearer
A. Eliot Shearer
JSJun Shen
Jun Shen
SASami Amr
Sami Amr
CMCynthia C. Morton
Cynthia C. Morton
RSRichard J. H. Smith
Richard J. H. Smith
Early intervention for newborns who are deaf or hard-of-hearing leads to improved language, communication, and social–emotional outcomes. Universal physiologic newborn hearing screening has been widely implemented across the United States with the goal of identifying newborns who are deaf or hard-of-hearing, thereby reducing time to diagnosis and intervention. The current physiologic newborn hearing screen is generally successful in accomplishing its goals but improvements could be made. In the past ten years, genetic testing has emerged as the most important etiological diagnostic test for evaluation of children with deafness and congenital cytomegalovirus has been recognized as a major cause of childhood deafness that may be treatable. A comprehensive newborn hearing screen that includes physiologic, genetic, and cytomegalovirus testing would have multiple benefits, including (1) identifying newborns with deafness missed by the current physiologic screen, (2) providing etiologic information, and (3) possibly decreasing the number of children lost to follow up. We present a framework for integrating limited genetic testing and cytomegalovirus screening into the current physiologic newborn hearing screening. We identify needed areas of research and include an overview of genome sequencing, which we believe will become available over the next decade as a complement to universal physiologic newborn hearing screening.

16 March 2020 in Current Protocols in Human Genetics
Verified
Journal Article
Open access
PDF file
JZJunyu Zhang
Junyu Zhang
YYYanyi Yao
Yanyi Yao
HHHaixian He
Haixian He
JSJun Shen
Jun Shen
Clinical interpretation of DNA sequence variants is a critical step in reporting clinical genetic testing results. Application of next‐generation sequencing technology in molecular genetic testing has facilitated diagnoses of genetic disorders in clinical practice. However, the large number of DNA sequence variants detected in clinical specimens, many of which have never been seen before, make clinical interpretation challenging. Recommendations by the American College of Medical Genetics and Genomics and the Association for Molecular Pathology (ACMG/AMP) have been widely adopted by clinical laboratories around the world to guide clinical interpretation of sequence variants. The ClinGen Sequence Variant Interpretation Working Group and various disease‐specific variant curation expert panels have also developed specifications for the ACMG/AMP recommendations. Despite these efforts to standardize variant interpretation in clinical practice, different laboratories may subjectively use professional judgment to determine which criteria are applicable when classifying a variant. In addition, clinicians and researchers who are not familiar with the variant interpretation process may have difficulty understanding clinical genetic reports and communicating the clinical significance of genetic testing results. Here we provide a step‐by‐step protocol for clinical interpretation of sequence variants, including practical examples. By following this protocol, clinical laboratory geneticists can interpret the clinical significance of sequence variants according to the ACMG/AMP recommendations and ClinGen framework. Furthermore, this article will help clinicians and researchers to understand variant classification in clinical genetic testing reports and evaluate the quality of the reports. © 2020 by John Wiley & Sons, Inc.Basic Protocol: Interpreting the clinical significance of sequence variantsSupport Protocol: Reevaluating the clinical significance of sequence variants

1 October 2019 in Genetics in Medicine
Verified
Journal Article
Closed access
PDF file
QWQiuju Wang
Qiuju Wang
JXJiale Xiang
Jiale Xiang
JSJun Sun
Jun Sun
YYYun Yang
Yun Yang
JGJing Guan
Jing Guan
ZPZhiyu Peng
Zhiyu Peng